Abstract:Background: The prognostic value of coronary artery calcium (CAC) combined with risk factor burdens in middle-aged and elderly patients with symptoms is unclear. Methods: A cohort study comprising 7432 middle-aged and elderly symptomatic patients (aged above 55 years) was conducted between December 2013 and September 2020. All patients had undergone coronary computed tomography angiography, and the Agatston score were used to measure CAC scores. The primary outcome was major adverse cardiac and cerebrovascular events (MACCE), which was defined as a composite outcome of nonfatal myocardial infarction, revascularization (percutaneous coronary intervention or coronary artery bypass graft), stroke, and cardiovascular death. Congestive heart failure, cardiogenic shock, malignant arrhythmia, and all-cause mortality were defined as the secondary outcomes. Results: There are 970 (13%) patients with CAC 0–10, 2331 (31%) patients with CAC 11–100, and 4131 (56%) patients with CAC ≥101. The proportion of patients aged 55–65 years, 65–75 years and ≥75 years was 40.7%, 38.1% and 21.2%, respectively. The total number of MACCEs over the 3.4 years follow-up period was 478. The percentage of CAC ≥101 was higher among the 75-year-old group than the 55–65-year-old group, increasing from 46.5% to 68.2%. With the increase in the CAC score, the proportion of patients aged ≥75 years increased from 12.9% to 25.8%, compared to those aged 55–65 years. The number of risk factors gradually increased as the CAC scores increased in the symptomatic patients aged over 55 years and the similar tendencies were observed among the different age subgroups. The proportion of non-obstructive coronary artery disease (CAD) was comparable between the three age groups (53.5% vs 51.9% vs 49.1%), but obstruction CAD increased with age. The incidence of MACCE in the group with CAC ≥101 and ≥4 risk factors was 1.71 times higher (95% confidence interval (CI) 1.01–2.92; p = 0.044) than the rate in the group with CAC ≥101 and 1 risk factor. In the CAC 0–10 group, the incidence of MACCE in patients aged ≥75 years was 12.65 times higher (95% CI: 6.74–23.75; p < 0.0001) than that in patients aged 55–65 years. By taking into account the combination of CAC score, age, and risk factor burden, the predictive power of MACCE can be increased (area under the curve (AUC) = 0.614). Conclusions: In symptomatic patients aged 55 or above, a rise in age, CAC scores, and risk factor burden was linked to a considerable risk of future MACCE. In addition, combining CAC scores, age and risk factors can more accurately predict outcomes for middle-aged and elderly patients with symptoms.

A combined circulating microRNA panel predicts the risk of vascular calcification in community-dwelling older adults with age strata differences

MicroRNA Predicts Cognitive Performance in Healthy Older Adults.

Circulating miR-129-3p in combination with clinical factors predicts vascular calcification in hemodialysis patients

Combined Associations of Hs-Crp and Cognitive Function with All-Cause Mortality among Oldest-Old Adults in Chinese Longevity Areas: a Prospective Cohort Study

Plasmatic MicroRNA Signatures in Elderly People with Stable and Unstable Angina.

Analysis of Plasma Mir-208A and Mir-370 Expression Levels for Early Diagnosis of Coronary Artery Disease

Association Between Elevated Plasma Microrna-223 Content and Severity of Coronary Heart Disease

Predictive Effects of Circulating Mir-221, Mir-130A and Mir-155 for Coronary Heart Disease: A Multi-Ethnic Study in China

Circulating MicroRNAs as easy-to-measure aging biomarkers in older breast cancer patients: correlation with chronological age but not with fitness/frailty status

Identification of circulating microRNA-126-3p as a new biomarker for coronary artery calcification

Transcriptome Analysis of Common and Diverged Circulating Mirnas Between Arterial and Venous During Aging.

Circulating MicroRNA-423-3p Improves the Prediction of Coronary Artery Disease in a General Population - Six-Year Follow-up Results from the China-Cardiovascular Disease Study -

Circulating MicroRNA Panel As a Diagnostic Marker for Hepatocellular Carcinoma

Interplay between Risk Factors and Coronary Artery Calcium in Middle-Aged and Elderly Symptomatic Patients

Additive contribution of microRNA-34a/b/c to human arterial ageing and atherosclerosis

Identification of miR136, miR155, and miR183 in vascular calcification in human peripheral arteries

Interaction between microRNA expression and classical risk factors in the risk of coronary heart disease

Signature Of Circulating Micrornas As Potential Biomarkers In Vulnerable Coronary Artery Disease

Prediction of P-tau/Aβ42 in the cerebrospinal fluid with blood microRNAs in Alzheimer’s disease

Early Detection of Coronary Artery Disease by Micro-RNA Analysis in Asymptomatic Patients Stratified by Coronary CT Angiography

MiR-665 Regulates Vascular Smooth Muscle Cell Senescence by Interacting With LncRNA GAS5/SDC1